REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Post-Market Registry
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
• Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device\* during treatment for acute ischemic stroke.
• Participant is 18 years of age or older.
Locations
United States
Michigan
McLaren Flint Hospital
RECRUITING
Flint
New York
Buffalo General Medical Center
RECRUITING
Buffalo
Texas
University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Stephanie Salisbury
rs.recanovaregistry@medtronic.com
612-979-7251
Time Frame
Start Date: 2026-07-13
Estimated Completion Date: 2031-07
Participants
Target number of participants: 1500
Related Therapeutic Areas
Sponsors
Leads: Medtronic Neurovascular Clinical Affairs